Study: Doxy-PEP not reaching high-risk groups

Fewer than one in 10 people who take HIV prevention medication also received an antibiotic that can lower their risk for STIs despite being in a high-risk population, a study of patients in New York City showed.
Black patients and people living in higher-poverty neighborhoods were the least likely to receive a prescription for doxycycline post-exposure prophylaxis (doxy-PEP), which involves taking the antibiotic within 72 hours of having unprotected sex.
Based on mounting evidence that showed doxy-PEP can reduce the risk for some STIs, the CDC endorsed its use in 2024 for transgender women and

Internet reaches patients long before exam room

Many Americans are getting information about their health from social media influencers and podcasts, whether or not they are actively looking for it.
And although most believe this information could be false or misleading, more than one-fifth say they act on it anyway, according to recent survey data (Pedroso et al).
“Every patient or parent is coming into their encounter with a self-diagnosis and preconceived ideas obtained from artificial intelligence or social media,” David R. Stukus, MD, a professor of clinical pediatrics at Nationwide Children’s Hospital who coauthored a paper on the

Longer operative time leads to ambulatory discharge failure

Results showed ambulatory discharge failure was common after minimally invasive lumbar fusion in older adults designated for ambulatory surgery, with moderate predictive value associated with longer operative duration.
“Workflow efficiency is an important consideration when planning for same-day discharge,” Sravisht Iyer, MD, attending spine surgeon at Hospital for Special Surgery and associate professor of orthopedics at Weill Cornell Medical School, told Healio about results presented at the Society for Minimally Invasive Spine Surgery Annual Forum. “Being efficient and getting surgery done

Powdered amniotic membrane may alleviate DED

NEW ORLEANS — TTAX03, a lyophilized, sterile powdered amniotic membrane, improved outcomes for individuals with mild to moderate dry eye disease, according to a speaker at the American Academy of Ophthalmology meeting.
Cryopreserved amniotic membrane has been used to target symptoms associated with dry eye disease, as Healio previously reported. However, TTAX03 (BioTissue), an investigational drug derived from placenta and umbilical cord, “was designed to overcome limitations of conventional amniotic membrane treatments, including reduced vision during wear due to the semitranslucent nature of

Genetic resilience for Alzheimer’s uncorrelated with genetic risk

SAN DIEGO — Genetic resilience to Alzheimer’s disease is associated with more dementia-free time, is uncorrelated with genetic risk for the disease and is gated by a patient’s vascular health, according to a speaker.
The protective effect of having higher genetic resilience is seen regardless of a patient’s APOE4 carrier status, Alokkumar Jha, PhD, assistant professor of research at Weill Cornell Medicine, said at the American Neurological Association’s 151st annual meeting. The findings shed light on questions about why some people with AD pathology convert faster than others, Jha said.
“APOE4

FDA approves Gazyva in primary membranous nephropathy

The FDA approved obinutuzumab for proteinuria remission for adults with primary membranous nephropathy at risk for disease progression, according to a press release from the agency.
Obinutuzumab (Gazyva, Genentech), a humanized monoclonal antibody that targets CD20 found on B cells, was previously approved for pediatric patients aged 2 years and older with idiopathic nephrotic syndrome and adults with active lupus nephritis, according to the release. It is now the first drug approved for adults with primary membranous nephropathy.
Results from the phase 3 MAJESTY clinical trial served as the

HHS provides patients with more access to health information

The HHS Office for Civil Rights issued a final rule modifying the Health Insurance Portability and Accountability Act of 1996 Privacy Rule, which established national standards to protect medical records and identifiable health information.
According to a press release, the HIPAA Privacy Rule: Changes to support coordinated care and individual engagement and reduce regulatory burdens final rule strengthens the rights of individuals to access their own protected health information, facilitates care coordination and reduces regulatory burdens for patients. A fact sheet released by HHS noted the

FDA approves Cosentyx for adults with polymyalgia rheumatica

The FDA has approved the interleukin-17 inhibitor secukinumab for the treatment of adults with polymyalgia rheumatica, expanding the armamentarium for the disease beyond steroids and a single biologic approved in 2023.
Secukinumab (Cosentyx, Novartis) is the second biologic approved by the FDA for PMR. Sarilumab (Kevzara; Sanofi, Regeneron), an injectable IL-6 receptor blocker, became the first biologic to gain FDA approval for the disease in March 2023. This latest approval indicates secukinumab 150 mg for patients who have had an inadequate response to corticosteroids or who cannot tolerate

Q&A: Rethinking the term ‘geriatric pregnancy’

Recent CDC data show there were 3,612,012 births in the United States last year, down less than 1% from 2024.
The birth rate decreased by 6% among women aged 20 to 24 years and by 4% among women woman aged 25 to 29.
In comparison, the birth rates among women aged 30 to 34 increased by 3% and by 2% among women aged 35 to 39.
Pregnancies among those aged 35 years or older at the date of delivery have historically been referred to as “geriatric pregnancies,” a term that dates back to the 1960s or 1970s and has persisted in medical literature, according to Sharrón L. Manuel, MD, PhD, FACOG, a